GGrantIndex
Sort

27,075 grants matching cholesterol

Lipid and Lipoprotein Metabolism in Atherosclerosis

$3,464,014
Alan M Fogelman · University Of California Los Angeles · P01 · FY2012 · HL

Lipid and Lipoprotein Metabolism in Atherosclerosis

$3,464,014
Alan M Fogelman · University Of California Los Angeles · P01 · FY2011 · HL

ACCORD

$3,440,654
Hertzel C Gerstein · Mcmaster University · N01 · FY2009 · HL

New mechanistic insights into how the gut metabolite urolithin A extends lifespan and prevents AD

$3,414,407
Julie Kay Andersen · Buck Institute For Research On Aging · RF1 · FY2018 · AG

Gut Liver Brain Biochemical Axis in Alzheimer's Disease

$3,407,970
Rima F Kaddurah-Daouk · Duke University · RF1 · FY2018 · AG

THE INTEGRATED DATA ACQUISITION CORE (IDAC)

$3,389,930
Michael P Harms · Washington University · U19 · FY2022 · AG

Molecular Determinants of Coronary Artery Disease

$3,384,713
Eric Jeffrey Topol · Cleveland Clinic Lerner Com-Cwru · P50 · FY2006 · HL

Identification of a missing key element underlying apoE2 neuroprotection in Alzheimer's disease and the aging brain

$3,382,940
Xianlin Han · University Of Texas Hlth Science Center · RF1 · FY2018 · AG

Lipid and Lipoprotein Metabolism in Atherosclerosis

$3,378,947
University Of California Los Angeles · P01 · FY2004 · HL

REPRIEVE - CCC - Lead Application

$3,367,267
Steven Kyle Grinspoon · Massachusetts General Hospital · U01 · FY2015 · HL

Genetic and Environmental Determinants of Triglycerides

$3,361,710
University Of Minnesota Twin Cities · U01 · FY2003 · HL

Molecular Determinants of Coronary Artery Disease

$3,353,613
Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P50 · FY2008 · HL

Imaging Probe Development Center

$3,349,437
Gary Leonard Griffiths · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL

Molecular Determinants of Coronary Artery Disease

$3,341,961
Edward Franklin Plow · Cleveland Clinic Lerner Com-Cwru · P50 · FY2007 · HL

Cell Signaling of Host Defense

$3,340,737
Michael B Fessler · National Institute Of Environmental Health Sciences · ZIA · FY2025 · ES

Lipid and Lipoprotein Metabolism in Atherosclerosis

$3,297,742
Alan M Fogelman · University Of California Los Angeles · P01 · FY2013 · HL

Pharmacogenomics and Risk of Cardiovascular Disease

$3,286,210
Children'S Hospital &Res Ctr At Oakland · U01 · FY2005 · HL

Lipid and Lipoprotein Metabolism in Atherosclerosis

$3,270,696
University Of California Los Angeles · P01 · FY2003 · HL

GENERAL CLINICAL RESEARCH CENTER

$3,263,457
Charles Ginsburg · Ut Southwestern Medical Center · M01 · FY2006 · RR

Use Of Animal Models To Study Lipid Genes That Modulate Atherosclerosis

$3,245,489
Alan Remaley · Heart, Lung, And Blood Institute · Z01 · FY2007 · HL

Alzheimer's Disease Research Center

$3,200,598
Scott A Small · Columbia University Health Sciences · P30 · FY2020 · AG

Alzheimer's Disease Research Center

$3,148,108
Scott A Small · Columbia University Health Sciences · P30 · FY2021 · AG

ACCORD

$3,136,468
J Thomas Bigger · Columbia University Health Sciences · N01 · FY2009 · HL

Leveraging Practice Based Research Networks to Accelerate Implementation and Diff

$3,117,856
James W Mold · University Of Oklahoma Hlth Sciences Ctr · R18 · FY2010 · HS

Alzheimer's Disease Research Center

$3,113,485
Scott A Small · Columbia University Health Sciences · P30 · FY2022 · AG